Patient safety incidents involving neuromuscular blockade: analysis of the UK National Reporting and Learning System data from 2006 to 2008

Neuromuscular blockade is a powerful anaesthetic tool that has the potential for significant adverse outcomes. We sought to explore the national picture by analysing incidents relating to neuromuscular blockade in anaesthesia from the National Reporting and Learning System from England and Wales between 2006 and 2008. We searched the database of incidents using SNOMED CT® search terms and reading the free text of relevant incidents. There were 231 incidents arising from the use or reversal of neuromuscular blocking agents. The main themes identified were: non‐availability of drugs (45 incidents, 19%), possible unintentional awareness under general anaesthesia (42 incidents, 18%), potential allergic reaction (31 incidents, 13%), problems with reversal of blockade (13 incidents, 6%), storage (13 incidents, 6%) and prolonged apnoea (11 incidents, 5%). We make recommendations to reduce human error in the use of neuromuscular blocking agents and on future incident reporting in anaesthesia.

[1]  T. Clutton-Brock,et al.  Association of Anaesthetists of Great Britain and Ireland , 1984 .

[2]  N. Stanhope,et al.  An evaluation of adverse incident reporting. , 1999, Journal of evaluation in clinical practice.

[3]  N. Stanhope,et al.  Reasons for not reporting adverse incidents: an empirical study. , 1999, Journal of evaluation in clinical practice.

[4]  S. Fasting,et al.  Adverse drug errors in anesthesia, and the impact of coloured syringe labels , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[5]  P Garnerin,et al.  Voluntary reporting system in anaesthesia: is there a link between undesirable and critical events? , 2000, Quality in health care : QHC.

[6]  J. Jagger,et al.  Safety in the OR. , 2000, Nursing.

[7]  B. Orser,et al.  Medication errors in anesthetic practice: a survey of 687 practitioners , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[8]  A F Merry,et al.  The Frequency and Nature of Drug Administration Error during Anaesthesia , 2001, Anaesthesia and intensive care.

[9]  R. James,et al.  1000 anaesthetic incidents: experience to date , 2003, Anaesthesia.

[10]  D. Christakis,et al.  Use of Incident Reports by Physicians and Nurses to Document Medical Errors in Pediatric Patients , 2004, Pediatrics.

[11]  A F Merry,et al.  Evidence‐based strategies for preventing drug administration errors during anaesthesia , 2004, Anaesthesia.

[12]  T. Caeiro,et al.  [Error in medicine]. , 2004, Medicina.

[13]  R Shaw,et al.  Adverse events and near miss reporting in the NHS , 2005, Quality and Safety in Health Care.

[14]  D. Grobbee,et al.  Impact of Anesthesia Management Characteristics on Severe Morbidity and Mortality , 2005, Anesthesiology.

[15]  Preventing errors with neuromuscular blocking agents. , 2006, Joint Commission journal on quality and patient safety.

[16]  C. Pope,et al.  Adverse events in anaesthetic practice: qualitative study of definition, discussion and reporting. , 2006, British journal of anaesthesia.

[17]  Improving the safety of neuromuscular blocking agents: a statement from the USP Safe Medication Use Expert Committee. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[18]  J. Santell.  Medication errors involving neuromuscular blocking agents. , 2006, Joint Commission journal on quality and patient safety.

[19]  A. Smith,et al.  Involving users in the design of a system for sharing lessons from adverse incidents in anaesthesia , 2006, Anaesthesia.

[20]  B. Sweeney,et al.  Recovery from neuromuscular blockade: a survey of practice. , 2006, Anaesthesia.

[21]  K. Makita,et al.  Medication errors in anesthesia: an 8-year retrospective analysis at an urban university hospital , 2008, Journal of Anesthesia.

[22]  A. Thomas,et al.  Patient safety incidents associated with equipment in critical care: a review of reports to the UK National Patient Safety Agency , 2008, Anaesthesia.

[23]  A. Merry.  Safety in anaesthesia: reporting incidents and learning from them , 2008, Anaesthesia.

[24]  A. N. Thomas,et al.  Medication‐related patient safety incidents in critical care: a review of reports to the UK National Patient Safety Agency * , 2008, Anaesthesia.

[25]  K. Catchpole,et al.  Safety in anaesthesia: a study of 12 606 reported incidents from the UK National Reporting and Learning System , 2008, Anaesthesia.

[26]  T. Fuchs-Buder,et al.  Monitoring neuromuscular block: an update , 2009, Anaesthesia.

[27]  M Koutantji,et al.  Feedback from incident reporting: information and action to improve patient safety , 2009, Quality & Safety in Health Care.

[28]  A. Smith,et al.  National critical incident reporting: improving patient safety. , 2009, British journal of anaesthesia.

[29]  B. McGrath,et al.  Patient safety incidents associated with airway devices in critical care: a review of reports to the UK National Patient Safety Agency , 2008, Anaesthesia.

[30]  R. Miller,et al.  Clinical implications of sugammadex , 2009, Anaesthesia.

[31]  F. Chung,et al.  Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. , 2009, The Cochrane database of systematic reviews.

[32]  J Viby-Mogensen,et al.  The undesirable effects of neuromuscular blocking drugs , 2009, Anaesthesia.

[33]  Andrew F. Smith.  Monitoring of neuromuscular blockade in general anaesthesia , 2010, The Lancet.

[34]  A Smith,et al.  Promoting patient safety through prospective risk identification: example from peri-operative care , 2010, Quality and Safety in Health Care.

[35]  F. Chung,et al.  Hypothermia For Neuroprotection In Adults After Cardiopulmonary Resuscitation , 2010, The Cochrane database of systematic reviews.